• You invest exclusively in passive ETFs — the subscription cost is hard to justify.
• You are a complete beginner — the data density will overwhelm rather than guide.
• You trade on price action and technicals — Stockopedia is fundamentals only.
• You manage a small portfolio — the annual fee will represent a meaningful drag.
• You need European market coverage as deep as UK coverage — it skews heavily UK.

Measures profitability (return on equity, return on capital, profit margins), earnings quality (cash conversion, accruals), and financial strength (debt levels, Piotroski F-Score, Altman Z-Score). A high Quality score means the business generates real profits from solid operations, not accounting tricks.

Combines classic valuation ratios including P/E, P/B, EV/EBITDA, Price/Cash Flow, and dividend yield. A high Value score means you are paying relatively little for each unit of earnings, assets, or cash flow — not that the stock is cheap in absolute terms, but cheap compared to the rest of the universe.

Tracks price momentum (12-month minus 1-month return, a standard academic factor) and earnings momentum (recent estimate revisions, earnings surprises). High Momentum stocks are already moving. The logic: quality and cheap alone is not enough; you want the market to start agreeing with you.

Filter by any combination of fundamentals, technicals, StockRank scores, and custom criteria. The screener ships with pre-built strategies based on well-documented approaches — Piotroski F-Score, Greenblatt Magic Formula, Benjamin Graham net-nets, Jim Slater Growth at a Reasonable Price. You can run these as-is or modify them for your own criteria. For systematic investors, this screener is the headline feature.

Each stock gets a single-page report aggregating financials, valuation ratios, forecast estimates, dividend history, risk indicators, and the full QVM scoring breakdown. The design is print-friendly and built for quick comparison across multiple stocks. Where a Bloomberg terminal presents the same data across dozens of screens, StockReports condenses it to a single view.

Import your holdings via CSV or connect directly, and the Folio tool calculates a composite rank for your entire portfolio. You can see immediately which holdings are dragging down the overall quality score and which are contributing positively. Sector exposure, geographic concentration, and diversification metrics are also surfaced. It is one of the more useful portfolio health-check tools in the retail segment.

Stockopedia has an unusually engaged subscriber community — partly because the product attracts methodical, process-driven investors who share research rather than hot tips. The Academy section covers factor investing, interpreting reports, and building screening strategies. Webinars are published regularly. For investors who are new to fundamental analysis, the educational layer alone has real value.

• You invest exclusively in passive UCITS ETFs — the tool adds no value to your process.
• You are a beginner who has not yet built a clear investment framework — start simpler.
• You trade primarily on price action and technicals — use TradingView instead.
• You want deep fundamental research on European small-caps — UK coverage is far stronger.
• You need qualitative analysis (moat ratings, management assessment) — Morningstar is better positioned there.
• You have a portfolio under £30,000 and need to optimise every basis point of drag.

You want rules, not intuition. You run a screen, apply criteria consistently, and follow the output without second-guessing it. Stockopedia was designed exactly for this profile — the QVM system is a framework for removing emotion, not adding complexity.

Full-time job, limited research hours. You need to make a portfolio decision in 20—30 minutes per stock, not a full weekend. StockReports and StockRanks compress the research workflow substantially. The time-saving case is real if you are already committed to individual stock picking.

Institutional-grade data on AIM-listed and smaller LSE companies is hard to access cheaply. Stockopedia’s data providers cover stocks that brokers’ own research teams do not touch. If you look for UK smaller-company opportunities, this is one of the strongest retail tools for that specific niche.

• No free plan. You cannot evaluate StockRanks on your actual holdings without committing to the trial and eventually to a subscription.
• Expensive at small portfolio sizes. The annual fee represents meaningful AUM drag below roughly £50,000—£100,000 depending on your tier.
• Charts are functional, not competitive. If you need charting, you will still need TradingView alongside Stockopedia.
• European coverage is thinner. UK stocks are the platform’s sweet spot. Continental European equities have narrower data depth on mid and small caps.
• Overwhelming for beginners. The data density is a feature for experienced investors and a barrier for those still learning basic fundamental analysis.
• Historical data depth varies. Some competitors offer 20 years of history; Stockopedia typically shows 5—10 years on most metric views, which limits longer-cycle backtesting.